Dali Pharmaceuticalco.,Ltd

    Dali Pharmaceuticalco.,Ltd

    SSSE:603963
    1.18
    CNY
    0.00
    (0.00%)
    Dali Pharmaceuticalco.,Ltd
    SSE:603963
    (Shanghai Stock Exchange)

    Recent

    price

    1.18

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    CNY
    2.59
    2.71
    3.08
    1.95
    1.68
    1.82
    1.73
    1.31
    0.66
    0.78
    0.6
    0.39
    0.28
    Revenue per Share
    0.86
    0.84
    0.91
    0.46
    0.38
    0.3
    0.05
    0.06
    0.01
    -0.19
    -0.08
    -0.09
    -0.11
    Basic EPS, GAAP
    -0.7
    -0.35
    0.68
    0.8
    0.52
    -0.08
    0.32
    -0.06
    -0.09
    -0.06
    -0.15
    -0.15
    -0.02
    Free Cash Flow per Basic Share
    0.01
    0.7
    0.81
    0.69
    0.56
    0.38
    0.05
    0.04
    - -
    0.05
    0.01
    0.01
    - -
    Dividend per Share
    1.25
    2.08
    2.2
    1.63
    1.14
    1.31
    0.97
    1.19
    0.99
    1.22
    1.13
    1.04
    0.96
    Book Value per Share
    1.19
    2.07
    2.2
    1.56
    1.12
    2.68
    1.75
    1.82
    1.28
    1.65
    1.65
    1.56
    1.49
    Tangible Book Value per Share
    110
    110
    110
    137
    165
    150
    232
    225
    323
    220
    221
    223
    219
    Basic Weighted Avg Shares
    285
    298
    339
    267
    276
    273
    401
    294
    214
    171
    132
    87
    62
    Sales/Revenue/Turnover
    38.69
    37.4
    34.76
    27.23
    26.38
    17.86
    2.48
    3.53
    -0.76
    -7.72
    -16.92
    -27.65
    -45.75
    Operating Margin (%)
    - -
    - -
    18
    18
    18
    19
    18
    16
    16
    18
    4
    2
    - -
    Depreciation Expense
    95
    92
    100
    62
    62
    44
    11
    14
    3
    -42
    -18
    -20
    -24
    Net Income, GAAP
    14.85
    14.79
    14.94
    14.81
    14.9
    15.06
    15.2
    21.13
    14.41
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    33.16
    30.92
    29.55
    23.33
    22.54
    16.3
    2.67
    4.59
    1.51
    -24.43
    -13.38
    -22.95
    -39.55
    Profit Margin (%)
    22
    71
    88
    72
    59
    289
    300
    297
    296
    258
    231
    212
    196
    Working Capital
    25
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    20
    38
    24
    15
    11
    LT Debt
    165
    257
    271
    241
    212
    463
    464
    468
    471
    419
    401
    381
    361
    Total Equity
    - -
    42.79
    33.93
    19.82
    23.18
    10.96
    1.72
    1.75
    -0.29
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    43.67
    37.25
    22.91
    26.37
    20.31
    4.74
    5.48
    1.05
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    50.28
    42.48
    26.81
    30.36
    23.2
    5.07
    5.48
    1.1
    -14.23
    -6.82
    -8.32
    -10.93
    Return on Common Equity (%)

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    9
    9
    9
    LT Borrowings
    14
    11
    11
    LT Finance Leases
    1
    1
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    220
    220
    220
    Market Capitalization
    2,442
    548
    671

    Working Capital

    CNY

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    279
    283
    273
    Cash, Cash Equivalents & STI
    215
    220
    208
    Accounts Receivable, Net
    2
    2
    8
    Inventories
    61
    60
    56
    Total Current Liabilities
    70
    81
    77
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    9
    9
    9
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.21%
    -3.76%
    -4.99%
    Free Cash Flow
    -105.57%
    15.49%
    1.52%
    Net Income, GAAP
    -162.43%
    -298.14%
    13.16%
    Sales/Revenue/Turnover
    -8.87%
    -26.14%
    -34.06%
    Total Cash Common Dividend
    154.52%
    328.92%
    -25.92%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    40
    30
    31
    32
    132
    2023
    37
    23
    14
    14
    87
    2024
    15
    12
    20
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.01
    - -
    - -
    - -
    -0.08
    2023
    -0.01
    - -
    - -
    - -
    -0.09
    2024
    -0.02
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    0.01
    2023
    - -
    - -
    - -
    - -
    0.01
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business